drug-retrosynthesis

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

• Third-party content exposure detected (high risk: 0.75). The required runtime workflow sends the user-supplied SMILES to IBM RXN via the rxn4chemistry API and then ingests the returned retrosynthetic pathway text/fields (e.g., retrosynthetic_paths with precursor names/SMILES) from the IBM server into the agent’s context; this is outsider-authored content from a public third-party service.